Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Lansoprazole 3-mg/mL Oral Liquid

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2007 - Pediatric Patients
View All Articles in Issue

Page(s):  74

Lansoprazole 3-mg/mL Oral Liquid Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Lansoprazole 3-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: FORMULATIONS, GERD, GASTROESOPHAGEAL REFLUX DISEASE, LANXOPRAZOLE, PROTON PUMP INHIBITOR

Related Categories: FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay
, Williams LaVonn A
Mar/Apr 2011
Pg. 124-128

Lansoprazole 3-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 74

Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 246

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 429

Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
Jan/Feb 2019
Pg. 58

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension
May/Jun 2018
Pg. 263

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Omeprazole 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 389

Pantoprazole Sodium 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 391

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C
, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Lansoprazole 3-mg/mL Oral Suspension
Jan/Feb 2025
Pg. 46

Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base
Spennacchio Antonio
, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
May/Jun 2023
Pg. 250-255

Famotidine 8-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 382

Ranitidine Hydrochloride 15-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2007
Pg. 161

The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Meissner Svenja
, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2020
Pg. 140-147

Compounding for a Pediatric Hospital
McElhiney Linda F
Nov/Dec 2005
Pg. 423-431

Return to Top